6 completed, 1 terminated. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 6, Terminated 1 |
Follow Drug Evaluation: new trials by email Literature Review of Drug Evaluation trials Research Report on Drug Evaluation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis X0002 Spray, Celecoxib capsules, placebo - KNEE OSTEOARTHRITIS | Phase 3 | Completed | Jiangsu XinChen-Techfields Pharma Co., LTD. | 180 | 2021-09-29 | 2023-03-07 |
| GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer GB491+ Fulvestrant, Placebo+Fulvestrant - Locally Advanced or Metastatic Breast Cancer | Phase 3 | Completed | Genor Biopharma Co., Ltd. | 275 | 2021-09-10 | 2024-10-10 |
| Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations Infigratinib, Placebo - Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer | Phase 3 | Terminated | QED Therapeutics, a BridgeBio company | 39 | 2020-03-11 | 2024-03-13 |
| Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria Test Drug (JDP-205), Active Control (Diphenhydramine) - Acute Urticaria | Phase 3 | Completed | JDP Therapeutics, Inc. | 262 | 2017-03-01 | 2019-11-27 |
| Combined Medication for Improved Analgesia in Superficial Pain Diclofenac and Atropine combination drug, Placebo - Pain | Phase 3 | Completed | Brigham and Women's Hospital | 100 | 2014-04-01 | 2018-07-03 |
| Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis Test group, Reference group - Postmenopausal Women With Osteoporosis | Phase 3 | Completed | Alvogen Korea | 201 | 2011-12-01 | 2016-11-01 |
| Micronutrient Supplementation in in Paediatric Pulmonary Tuberculosis Zinc, Micronutrient without zinc, Micronutrient with zinc - Tuberculosis | Phase 3 | Completed | All India Institute of Medical Sciences | 403 | 2008-12-01 | 2016-02-10 |
Breast Neoplasms (1) · Osteoarthritis, Knee (1) · Pain (1) · Tuberculosis (1)
All India Institute of Medical Sciences (1) · Alvogen Korea (1) · Brigham and Women's Hospital (1) · Genor Biopharma Co., Ltd. (1) · JDP Therapeutics, Inc. (1) · Jiangsu XinChen-Techfields Pharma Co., LTD. (1) · QED Therapeutics, a BridgeBio company (1)
United States (3) · Canada (2) · China (2) · Belgium (1) · Bulgaria (1) · France (1) · Germany (1) · Greece (1) · India (1) · Italy (1) · Netherlands (1) · South Korea (1) · Spain (1) · United Kingdom (1)
Binghe Xu, PhD (1) · David van Veenhuyzen, M.B., Ch.B., M.Pharm.Med. (1) · Moo-il Kang, MD, PhD (1) · Robert R Edwards, PHD (1) · Sushil Kr Kabra, MD (1)
PMID 25332327, PMID 28178072, PMID 32653333, PMID 35608106, PMID 36058810, PMID 36877132, PMID 39820749
2019 (1)